Investors on the quest for market-beating returns often employ the strategy of stock picking. Making informed choices in stocks can greatly amplify your wealth.
As of close of business last night, Hookipa Pharma Inc’s stock clocked out at $1.51, down -6.79% from its previous closing price of $1.62. In other words, the price has decreased by -$6.79 from its previous closing price. On the day, 0.23 million shares were traded. HOOK stock price reached its highest trading level at $1.62 during the session, while it also had its lowest trading level at $1.45.
Ratios:
To gain a deeper understanding of HOOK’s stock, we examine its different ratios. For the most recent quarter (mrq), Quick Ratio is recorded 3.61 and its Current Ratio is at 3.61. In the meantime, Its Debt-to-Equity ratio is 0.02 whereas as Long-Term Debt/Eq ratio is at 0.01.
Upgrades & Downgrades
In addition, analysts’ ratings and any changes thereto give investors an idea of the stock’s future direction. In the most recent recommendation for the company, RBC Capital Mkts on December 20, 2024, Downgraded its rating to Sector Perform and sets its target price to $2 from $48 previously.
On November 15, 2024, RBC Capital Mkts reiterated its Outperform rating and also upped its target price recommendation from $50 to $48.
BofA Securities Downgraded its Buy to Underperform on December 02, 2022, while the target price for the stock was maintained at $0.50.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, HOOK now has a Market Capitalization of 18405540 and an Enterprise Value of -21274400. For the stock, the TTM Price-to-Sale (P/S) ratio is 1.97 while its Price-to-Book (P/B) ratio in mrq is 0.53. Its current Enterprise Value per Revenue stands at -2.275 whereas that against EBITDA is 0.294.
Stock Price History:
The Beta on a monthly basis for HOOK is 0.90, which has changed by -0.80641025 over the last 52 weeks, in comparison to a change of 0.09362543 over the same period for the S&P500. Over the past 52 weeks, HOOK has reached a high of $105.00, while it has fallen to a 52-week low of $0.72. The 50-Day Moving Average of the stock is 33.84%, while the 200-Day Moving Average is calculated to be -42.43%.
Shares Statistics:
It appears that HOOK traded 116.43K shares on average per day over the past three months and 276830 shares per day over the past ten days. A total of 9.67M shares are outstanding, with a floating share count of 6.98M. Insiders hold about 42.76% of the company’s shares, while institutions hold 21.09% stake in the company. Shares short for HOOK as of 1745971200 were 29869 with a Short Ratio of 0.26, compared to 1743379200 on 52004. Therefore, it implies a Short% of Shares Outstanding of 29869 and a Short% of Float of 0.38.
Dividends & Splits
Against a Trailing Annual Dividend Yield of 0.0
Earnings Estimates
Investors are keenly observing as 1.0 analysts analyze and rate the current performance of Hookipa Pharma Inc (HOOK) in the stock market.The consensus estimate for the next quarter is -$0.71, with high estimates of -$0.71 and low estimates of -$0.71.
Analysts are recommending an EPS of between -$3.32 and -$3.32 for the fiscal current year, implying an average EPS of -$3.32. EPS for the following year is -$1.85, with 2.0 analysts recommending between -$1.56 and -$2.14.
Revenue Estimates
In the current quarter, 1 analysts expect revenue to total $3.38M. It ranges from a high estimate of $3.38M to a low estimate of $3.38M. As of the current estimate, Hookipa Pharma Inc’s year-ago sales were $1.29MFor the next quarter, 1 analysts are estimating revenue of $3.38M. There is a high estimate of $3.38M for the next quarter, whereas the lowest estimate is $3.38M.
A total of 1 analysts have provided revenue estimates for HOOK’s current fiscal year. The highest revenue estimate was $12.13M, while the lowest revenue estimate was $12.13M, resulting in an average revenue estimate of $12.13M. In the same quarter a year ago, actual revenue was $43.95MBased on 1 analysts’ estimates, the company’s revenue will be $1M in the next fiscal year. The high estimate is $1M and the low estimate is $1M.
